Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
Putzki N, Yaldizli O, Bühler R, Schwegler G, Curtius D, Tettenborn B. Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland. Eur Neurol 2010; 63:101-106.
Jan 1, 2010
Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
Jan 1, 2010
Eur Neurol 2010; 63:101-106
Putzki Norman, Yaldizli Ozgür, Bühler Robert, Schwegler Guido, Curtius Daniela, Tettenborn Barbara
more
